What is the primary reason why Salmeterol should not be used as monotherapy for the treatment of asthma?
Show answer and explanation
Correct answer: It has a very slow onset of action and increases the risk of asthma-related death
Long-Acting Beta-2 Agonists (LABAs) like Salmeterol do not treat underlying inflammation. When used alone in asthma, they can mask worsening inflammation, leading to a higher risk of fatal asthma attacks; they must always be paired with an inhaled corticosteroid.
Keep practicing
More Beta-2 Agonists questions
- Which electrolyte abnormality is a well-known systemic side effect of high-dose Beta-2 agonist therapy?
- Which of the following drugs is a Long-Acting Beta-2 Agonist (LABA) that, unlike Salmeterol, has a rapid onset of action?
- A patient using an Albuterol inhaler frequently complains of 'shaking hands.' What is the pharmacological basis for this tremor?
- Levalbuterol is marketed as a 'pure' version of Albuterol because it contains only which isomer?
- Terbutaline is sometimes administered via subcutaneous injection for which non-respiratory emergency?
- What is the primary benefit of using a 'spacer' or holding chamber with a metered-dose inhaler (MDI) of Albuterol?